CNS Pharmaceuticals CNSP 深 沪
等待开盘 08-20 09:30:00 美东时间
5.83
-0.031
-0.54%
华盛通- 最 高6.19
- 今 开6.07
- 成交量 2.14万股
- 最 低 5.7001
- 昨 收 5.8615
- 总市值 852.02万
- 52周最高 10.588
- 市盈率 静 --
- 换手率 1.47%
- 52周最低 1.90
- 委 比 -98.57%
- 总股本 146.14万
- 历史最高 5121000.00
- 量 比 1.94
- 振 幅 8.36%
- 历史最低 1.90
- 每 手 1
- 风险率 2.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CNS Pharmaceuticals Q2 EPS $(0.38) Misses $(0.24) Estimate
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.24) by 58.33 percent. This is a 94.08 percent increase over losses of $(6.42) per share from the same period last year.
08-12 20:03
快讯 | CNS Pharmaceuticals第二季度净利润为260万美元
CNS Pharmaceuticals Q2 Net Income USD -2.6 Million
08-12 20:00
CNS Pharmaceuticals Q1 EPS $(7.30) Misses $(5.37) Estimate
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(7.30) per share which missed the analyst consensus estimate of $(5.37) by 35.94 percent. This is a 61.44 percent increase over losses of $(18.93) per share
05-14 20:28
What's Going On With CNS Pharmaceuticals Stock On Wednesday?
CNS Pharmaceuticals plans a pivot to an acquisition-led strategy, capital raise, and technicals signal momentum with caution.
05-06 21:51
3 Penny Stocks to Watch Now, 5/5/26
CNS Pharmaceuticals ($CNSP), Elong Power Holding ($ELPW), and Skycorp Solar Gro...
05-06 00:22
Gold Falls Over 2%; US Factory Orders Rise In March
US stocks traded lower with Dow down 0.4%. NASDAQ up 0.07% while S&P 500 fell 0.03%. Norwegian Cruise Line beat Q1 estimates but cut FY2026 guidance.
05-05 00:05
Why Is CNS Pharmaceuticals Stock (CNSP) Up Today?
CNS Pharmaceuticals stock underwent a massive rally alongside a $22.5 million p...
05-04 21:58
Dow Falls Over 150 Points; Tyson Foods Posts Upbeat Earnings
US stocks fell, Dow dropped 150 points. Dow at 49,321.96, NASDAQ at 25,109.76, S&P 500 at 7,223.30. Tyson Foods beat earnings, stock up. Energy and Xanadu Quantum down.
05-04 21:40
CNS Pharmaceuticals Enters Securities Purchase Agreements For ~$22.5M Private Placement Of 650,000 Shares At $2.30 Per Share And Warrants To Purchase Up To ~9.1M Shares At Purchase Price $2.299 Per Warrant
The private placement includes participation from institutional healthcare investors, including ADAR1 Capital, Ikarian Capital, Stonepine Capital Management and Nazare Partners.Pursuant to the terms of the securities
05-04 19:13
